Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Strategic planning to reduce the burden of stroke among veterans: using simulation modeling to inform decision making.

Lich KH, Tian Y, Beadles CA, Williams LS, Bravata DM, Cheng EM, Bosworth HB, Homer JB, Matchar DB.

Stroke. 2014 Jul;45(7):2078-84. doi: 10.1161/STROKEAHA.114.004694. Epub 2014 Jun 12.

2.

Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.

Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM.

Ann Intern Med. 2010 Apr 20;152(8):481-7, W170-3. doi: 10.7326/0003-4819-152-8-201004200-00212. Epub 2010 Mar 1.

PMID:
20194225
3.

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.

Ann Intern Med. 2011 Jan 4;154(1):1-11. doi: 10.7326/0003-4819-154-1-201101040-00289. Epub 2010 Nov 1.

PMID:
21041570
4.

Linked Sensitivity Analysis, Calibration, and Uncertainty Analysis Using a System Dynamics Model for Stroke Comparative Effectiveness Research.

Tian Y, Hassmiller Lich K, Osgood ND, Eom K, Matchar DB.

Med Decis Making. 2016 Apr 18. pii: 0272989X16643940. [Epub ahead of print]

PMID:
27091379
5.

Quality Enhancement Research Initiative in stroke: prevention, treatment, and rehabilitation.

Oddone E, Brass LM, Booss J, Goldstein L, Alley L, Horner R, Rosen A, Kaplan L.

Med Care. 2000 Jun;38(6 Suppl 1):I92-104. Review.

PMID:
10843274
6.

Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?

Cadilhac DA, Carter R, Thrift AG, Dewey HM.

Stroke. 2012 May;43(5):1370-5. doi: 10.1161/STROKEAHA.111.634949. Epub 2012 Feb 23.

7.

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Juusola JL, Brandeau ML, Owens DK, Bendavid E.

Ann Intern Med. 2012 Apr 17;156(8):541-50. doi: 10.7326/0003-4819-156-8-201204170-00001.

8.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

9.

Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.

Jönsson B, Carides GW, Burke TA, Dasbach EJ, Lindholm LH, Dahlöf B; LIFE Study Group.

J Hypertens. 2005 Jul;23(7):1425-31.

PMID:
15942467
10.

Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.

Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD.

J Am Coll Cardiol. 2013 Mar 26;61(12):1250-8.

11.

Cost-effectiveness of optimizing acute stroke care services for thrombolysis.

Penaloza-Ramos MC, Sheppard JP, Jowett S, Barton P, Mant J, Quinn T, Mellor RM, Sims D, Sandler D, McManus RJ; Birmingham and Black Country Collaborations for Leadership in Applied Health Research and Care Investigators.

Stroke. 2014 Feb;45(2):553-62. doi: 10.1161/STROKEAHA.113.003216. Epub 2014 Jan 2.

12.

Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.

Saborido CM, Hockenhull J, Bagust A, Boland A, Dickson R, Todd D.

Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310. Review.

13.
14.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

15.

Does inpatient quality of care differ by age among US veterans with ischemic stroke?

Chumbler NR, Jia H, Phipps MS, Li X, Ordin D, Vogel WB, Castro JG, Myers J, Williams LS, Bravata DM.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):844-51. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.019. Epub 2011 Jun 8.

PMID:
21641817
16.

Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.

Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM.

J Allergy Clin Immunol. 2001 Jul;108(1):39-46.

PMID:
11447380
17.

The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.

Wilson EC, Emery JD, Kinmonth AL, Prevost AT, Morris HC, Humphrys E, Hall PN, Burrows N, Bradshaw L, Walls J, Norris P, Johnson M, Walter FM.

Value Health. 2013 Mar-Apr;16(2):356-66. doi: 10.1016/j.jval.2012.12.008.

18.

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

Ann Intern Med. 2004 May 4;140(9):689-99.

PMID:
15126252
19.
20.

Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.

Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA.

J Gen Intern Med. 2012 Jun;27(6):669-76. doi: 10.1007/s11606-011-1962-8. Epub 2012 Jan 4.

Items per page

Supplemental Content

Write to the Help Desk